Xiaolai Yang

425 total citations
12 papers, 366 citations indexed

About

Xiaolai Yang is a scholar working on Molecular Biology, Pharmacology and Biochemistry. According to data from OpenAlex, Xiaolai Yang has authored 12 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Pharmacology and 2 papers in Biochemistry. Recurrent topics in Xiaolai Yang's work include Pharmacological Effects of Natural Compounds (5 papers), Ginseng Biological Effects and Applications (3 papers) and Phytochemicals and Antioxidant Activities (2 papers). Xiaolai Yang is often cited by papers focused on Pharmacological Effects of Natural Compounds (5 papers), Ginseng Biological Effects and Applications (3 papers) and Phytochemicals and Antioxidant Activities (2 papers). Xiaolai Yang collaborates with scholars based in China. Xiaolai Yang's co-authors include Yongjie Wu, Xiaoxia Wang, Bin Ge, Tiankang Guo, Jing Zhai, Lining Yang, Yanhong Wang, Xia Liu, Yongqing Cai and Xiongfei Yang and has published in prestigious journals such as Molecules, Cell Death and Disease and Biomedicine & Pharmacotherapy.

In The Last Decade

Xiaolai Yang

12 papers receiving 353 citations

Peers

Xiaolai Yang
Xiaolai Yang
Citations per year, relative to Xiaolai Yang Xiaolai Yang (= 1×) peers Xuejiao Gao

Countries citing papers authored by Xiaolai Yang

Since Specialization
Citations

This map shows the geographic impact of Xiaolai Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolai Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolai Yang more than expected).

Fields of papers citing papers by Xiaolai Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolai Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolai Yang. The network helps show where Xiaolai Yang may publish in the future.

Co-authorship network of co-authors of Xiaolai Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolai Yang. A scholar is included among the top collaborators of Xiaolai Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolai Yang. Xiaolai Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Xu, Yue, Qian Lü, Qian Zhao, et al.. (2022). Evolution of gene expression signature in mammary gland stem cells from neonatal to old mice. Cell Death and Disease. 13(4). 335–335. 3 indexed citations
2.
Yang, Xiaolai, et al.. (2021). Research on Indoor 3D Positioning Algorithm Based on Bluetooth RSSI/AOA. 181–185. 1 indexed citations
3.
Yang, Xiaolai, et al.. (2017). Delayed genital blisters following iodixanol administration. Clinical Toxicology. 55(8). 939–940. 1 indexed citations
4.
Yang, Xiaolai, Jian Zou, Hongyi Cai, et al.. (2017). Ginsenoside Rg3 inhibits colorectal tumor growth via down-regulation of C/EBPβ/NF-κB signaling. Biomedicine & Pharmacotherapy. 96. 1240–1245. 51 indexed citations
5.
Gao, Xiang, et al.. (2015). The role of endoplasmic reticulum stress in endothelial dysfunction induced by homocysteine thiolactone. Fundamental and Clinical Pharmacology. 29(3). 252–259. 32 indexed citations
6.
Zou, Jian, Xiaohong Tracey Gan, Xiaoxiao Chen, et al.. (2014). Alpha-lipoic acid attenuates cardiac hypertrophy via inhibition of C/EBPβ activation. Molecular and Cellular Endocrinology. 399. 321–329. 15 indexed citations
7.
Yang, Xiaolai, Tiankang Guo, Yanhong Wang, et al.. (2012). Ginsenoside Rd attenuates the inflammatory response via modulating p38 and JNK signaling pathways in rats with TNBS-induced relapsing colitis. International Immunopharmacology. 12(2). 408–414. 54 indexed citations
8.
Yang, Xiaolai, et al.. (2012). Therapeutic effect of ginsenoside Rd in rats with TNBS-induced recurrent ulcerative colitis. Archives of Pharmacal Research. 35(7). 1231–1239. 40 indexed citations
9.
Wang, Yanhong, Bin Ge, Xiaolai Yang, et al.. (2011). Proanthocyanidins from grape seeds modulates the nuclear factor-kappa B signal transduction pathways in rats with TNBS-induced recurrent ulcerative colitis. International Immunopharmacology. 11(10). 1620–1627. 89 indexed citations
10.
Yang, Xiaolai, Yongqing Cai, Lı Wang, et al.. (2011). Proanthocyanidins from Grape Seeds Modulate the NF-κB Signal Transduction Pathways in Rats with TNBS-Induced Ulcerative Colitis. Molecules. 16(8). 6721–6731. 31 indexed citations
11.
Wang, Yan‐Hong, Xiaolai Yang, Li Wang, et al.. (2010). Effects of proanthocyanidins from grape seed on treatment of recurrent ulcerative colitis in rats. Canadian Journal of Physiology and Pharmacology. 88(9). 888–898. 48 indexed citations
12.
Yang, Xiaolai. (2005). Protective effects of grape seed proanthocynidins extract on acetic acid-induced colitis in rats. Zhongguo linchuang yaolixue yu zhiliaoxue. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026